First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients

This study evaluated the safety and feasibility of transendocardial injections of VentriGel, a cardiac extracellular matrix hydrogel, in early and late post–myocardial infarction (MI) patients with left ventricular (LV) dysfunction. VentriGel was delivered in 15 patients with moderate LV dysfunction...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JACC Basic Transl Sci
Main Authors: Traverse, Jay H., Henry, Timothy D., Dib, Nabil, Patel, Amit N., Pepine, Carl, Schaer, Gary L., DeQuach, Jessica A., Kinsey, Adam M., Chamberlin, Paul, Christman, Karen L.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
CLINICAL RESEARCH
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834965/
https://ncbi.nlm.nih.gov/pubmed/31709316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2019.07.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados